Armata Pharmaceuticals (ARMP) said Thursday the US Food and Drug Administration approved the company's investigational new drug application to start a...
Armata Pharmaceuticals (ARMP) said late Thursday that the Cystic Fibrosis Foundation and Innoviva Strategic Opportunities have made a combined equity...
MMTEC (MTC), the Chinese online trading service platform company, led the decliners, with shares down 8.2% lower. Opera Ltd. (OPRA), the Norwegian-based...
Armata Pharmaceuticals (ARMP) said Monday that Chief Executive Officer Todd Patrick is retiring, effective immediately. President and Chief Development...
| Address | 4503 Glencoe Avenue Los Angeles, California 90292 |
| Phone | +1.310.655.2928 |
| Number of Employees | 31 |
| Recent SEC Filing | 11/10/2021 10-Q |
| Chief Executive Officer & Director | Brian C. Varnum |
| Vice President-Operations | Duane A. Morris |
| Chief Financial Officer | Steven Robert Martin |
| Vice President-Clinical Development | Mina Pastagia |
| Price Open | $4.83 |
| Previous Close | $4.91 |
| 52 Week Range | $2.56 - 10.48 |
| Market Capitalization | $121.9 M |
| Shares Outstanding | 27.1 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 03/17/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$1.12 |
| Beta vs. S&P 500 | N/A |
| Revenue | $0.00 |
| Net Profit Margin | -594.94% |
| Return on Equity | -90.20% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
